Advocate

Country: European Union

Language: Estonian

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

imidaklopriid, moxidectin

Available from:

Bayer Animal Health GmbH

ATC code:

QP54AB52

INN (International Name):

imidacloprid, moxidectin

Therapeutic group:

Dogs; Cats; Ferrets

Therapeutic area:

Antibakteriaalsed tooted, insektitsiidid ja repellendid

Therapeutic indications:

DogsFor koertele, kes kannatavad või ohustab, segatud parasiitnakkused:ravi ja ennetamine kirbu nakatumise (Ctenocephalides felis),ravi hammustamine täid (Trichodectes canis),ravi kõrva lesta nakatumise (Otodectes cynotis), sarcoptic mange (põhjustatud Sarcoptes scabiei var. canis), demodicosis (põhjustatud Demodex canis),ennetamine heartworm haigus (L3 ja L4 vastsed Dirofilaria immitis),ravi ringleva microfilariae (Dirofilaria immitis),ravi naha dirofilariosis (täiskasvanud etappidel Dirofilaria repens)vältimise naha dirofilariosis (L3 vastsed Dirofilaria repens),vähendada ringleva microfilariae (Dirofilaria repens),ennetamine angiostrongylosis (L4 vastsed ja ebaküps täiskasvanud Angiostrongylus vasorum),ravi Angiostrongylus vasorum ja Crenosoma vulpis,ennetamine spirocercosis (Spirocerca lupi),ravi Eucoleus (syn. Capillaria) boehmi (täiskasvanud),ravi silma uss Thelazia callipaeda (täiskasvanud),ravi infektsioonid seedetrakti ümarusse (L4 vastsed, ebaküps täiskasvanud ja täiskasvanute Toxocara canis, Ancylostoma caninum ja Uncinaria stenocephala, täiskasvanute Toxascaris leonina ja Trichuris vulpis). Preparaati võib kasutada osana ravi strateegia kirbu allergia dermatiidi (FAD). CatsFor kassid kannatavad, või oht, segatud parasiitnakkused:ravi ja ennetamine kirbu nakatumise (Ctenocephalides felis),ravi kõrva lesta nakatumise (Otodectes cynotis),ravi notoedric mange (Notoedres cati),ravi lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (täiskasvanutel),ennetamine lungworm haigus (L3/L4 vastsed Aelurostrongylus abstrusus),ravi lungworm Aelurostrongylus abstrusus (täiskasvanud),ravi silma uss Thelazia callipaeda (täiskasvanud),ennetamine heartworm haigus (L3 ja L4 vastsed Dirofilaria immitis),ravi infektsioonid seedetrakti ümarusse (L4 vastsed, ebaküps täiskasvanud ja täiskasvanute Toxocara cati ja Ancylostoma tubaeforme). Preparaati võib kasutada osana ravi strateegia kirbu allergia dermatiidi (FAD). FerretsFor tuhkrud, kes kannatavad või ohustab, segatud parasiitnakkused:ravi ja ennetamine kirbu nakatumise (Ctenocephalides felis),ennetamine heartworm haigus (L3 ja L4 vastsed Dirofilaria immitis).

Product summary:

Revision: 23

Authorization status:

Volitatud

Authorization date:

2003-04-02

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Selle veterinaarravimi ajakohane teave on veterinaarravimite teabe
veebilehel.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Selle veterinaarravimi ajakohane teave on veterinaarravimite teabe
veebilehel.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 31-01-2024
Public Assessment Report Public Assessment Report Bulgarian 29-01-2024
Patient Information leaflet Patient Information leaflet Spanish 31-01-2024
Public Assessment Report Public Assessment Report Spanish 29-01-2024
Patient Information leaflet Patient Information leaflet Czech 31-01-2024
Public Assessment Report Public Assessment Report Czech 29-01-2024
Patient Information leaflet Patient Information leaflet Danish 31-01-2024
Public Assessment Report Public Assessment Report Danish 29-01-2024
Patient Information leaflet Patient Information leaflet German 31-01-2024
Public Assessment Report Public Assessment Report German 29-01-2024
Patient Information leaflet Patient Information leaflet Greek 31-01-2024
Public Assessment Report Public Assessment Report Greek 29-01-2024
Patient Information leaflet Patient Information leaflet English 31-01-2024
Public Assessment Report Public Assessment Report English 29-01-2024
Patient Information leaflet Patient Information leaflet French 31-01-2024
Public Assessment Report Public Assessment Report French 29-01-2024
Patient Information leaflet Patient Information leaflet Italian 31-01-2024
Public Assessment Report Public Assessment Report Italian 29-01-2024
Patient Information leaflet Patient Information leaflet Latvian 31-01-2024
Public Assessment Report Public Assessment Report Latvian 29-01-2024
Patient Information leaflet Patient Information leaflet Lithuanian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 31-01-2024
Public Assessment Report Public Assessment Report Lithuanian 29-01-2024
Patient Information leaflet Patient Information leaflet Hungarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 31-01-2024
Public Assessment Report Public Assessment Report Hungarian 29-01-2024
Patient Information leaflet Patient Information leaflet Maltese 31-01-2024
Public Assessment Report Public Assessment Report Maltese 29-01-2024
Patient Information leaflet Patient Information leaflet Dutch 31-01-2024
Public Assessment Report Public Assessment Report Dutch 29-01-2024
Patient Information leaflet Patient Information leaflet Polish 31-01-2024
Public Assessment Report Public Assessment Report Polish 29-01-2024
Patient Information leaflet Patient Information leaflet Portuguese 31-01-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 31-01-2024
Public Assessment Report Public Assessment Report Portuguese 29-01-2024
Patient Information leaflet Patient Information leaflet Romanian 31-01-2024
Public Assessment Report Public Assessment Report Romanian 29-01-2024
Patient Information leaflet Patient Information leaflet Slovak 31-01-2024
Public Assessment Report Public Assessment Report Slovak 29-01-2024
Patient Information leaflet Patient Information leaflet Slovenian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 31-01-2024
Public Assessment Report Public Assessment Report Slovenian 29-01-2024
Patient Information leaflet Patient Information leaflet Finnish 31-01-2024
Public Assessment Report Public Assessment Report Finnish 29-01-2024
Patient Information leaflet Patient Information leaflet Swedish 31-01-2024
Public Assessment Report Public Assessment Report Swedish 29-01-2024
Patient Information leaflet Patient Information leaflet Norwegian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 31-01-2024
Public Assessment Report Public Assessment Report Norwegian 29-01-2024
Patient Information leaflet Patient Information leaflet Icelandic 31-01-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 31-01-2024
Public Assessment Report Public Assessment Report Icelandic 29-01-2024
Patient Information leaflet Patient Information leaflet Croatian 31-01-2024
Public Assessment Report Public Assessment Report Croatian 29-01-2024

Search alerts related to this product

View documents history